ConductScience.org, home
A Study to Evaluate the Safety and Efficacy of CR845 in Chronic Kidney Disease Patients With Moderate-to-Severe Pruritus
API referenceFor AI assistants

Trial · NCT03617536

Adverse events200

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

121 to 140 of 200

Download this page as JSON
TypeEventOrgan systemGroupAffectedAt riskEvents
seriousArteriovenous fistula site complicationInjury, poisoning and procedural complicationsCR845 0.25 mg Oral Tablet069
seriousArteriovenous fistula site complicationInjury, poisoning and procedural complicationsCR845 0.5 mg Oral Tablet166
seriousArteriovenous fistula site complicationInjury, poisoning and procedural complicationsCR845 1 mg Oral Tablet067
seriousArteriovenous fistula site complicationInjury, poisoning and procedural complicationsPlacebo Oral Tablet067
seriousClavicle fractureInjury, poisoning and procedural complicationsCR845 0.25 mg Oral Tablet069
seriousClavicle fractureInjury, poisoning and procedural complicationsCR845 0.5 mg Oral Tablet066
seriousClavicle fractureInjury, poisoning and procedural complicationsCR845 1 mg Oral Tablet167
seriousClavicle fractureInjury, poisoning and procedural complicationsPlacebo Oral Tablet067
seriousHip fractureInjury, poisoning and procedural complicationsCR845 0.25 mg Oral Tablet069
seriousHip fractureInjury, poisoning and procedural complicationsCR845 0.5 mg Oral Tablet166
seriousHip fractureInjury, poisoning and procedural complicationsCR845 1 mg Oral Tablet067
seriousHip fractureInjury, poisoning and procedural complicationsPlacebo Oral Tablet067
seriousPelvic fractureInjury, poisoning and procedural complicationsCR845 0.25 mg Oral Tablet069
seriousPelvic fractureInjury, poisoning and procedural complicationsCR845 0.5 mg Oral Tablet066
seriousPelvic fractureInjury, poisoning and procedural complicationsCR845 1 mg Oral Tablet167
seriousPelvic fractureInjury, poisoning and procedural complicationsPlacebo Oral Tablet067
seriousHepatic enzyme increasedInvestigationsCR845 0.25 mg Oral Tablet069
seriousHepatic enzyme increasedInvestigationsCR845 0.5 mg Oral Tablet066
seriousHepatic enzyme increasedInvestigationsCR845 1 mg Oral Tablet167
seriousHepatic enzyme increasedInvestigationsPlacebo Oral Tablet067

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous pageNext page

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03617536/events?page=7

API referenceFor AI assistants